LANGLEY, BC, Dec. 29, 2022 /CNW/ - ADENTRA Inc. ("ADENTRA" or the "Company") (TSX: ADEN)" is pleased to announce that the Toronto Stock Exchange (the "TSX") has accepted a notice filed by the Company of its intention to make a Normal Course Issuer Bid (the "Bid") to be transacted through the facilities of the TSX or any alternative Canadian trading system.
The notice provides that the Company may, during the period commencing on January 3, 2023 and ending on December 31, 2023, purchase up to 1,735,401 of its common shares ("Shares") in total, being approximately 10% of the Company's Public Float (as that term is defined in the policies of the TSX) based on 22,657,173 issued and outstanding Shares as at December 20, 2022. The price which the Company will pay for any such Shares will be the prevailing market price at the time of acquisition. The actual number of Shares which may be purchased pursuant to the Bid will be determined by management of the Company. All Shares will be purchased for cancellation.
Pursuant to TSX policies, the maximum number of Shares that may be purchased in one day pursuant to the Bid will be 11,246, representing 25% of the average daily trading volume of the Shares on the TSX. In addition, the Company may make, once per week, a block purchase of Shares not directly or indirectly owned by insiders of the Company, in accordance with TSX policies.
The Board of Directors believes that during the course of the Bid the market price of the Shares may not, from time to time, reflect the underlying value of the Company. As a result, depending upon future price movements and other factors, the Board of Directors believes that the purchase of the Shares may be in the best interests of the Company and its shareholders. Furthermore, any purchases are expected to benefit all persons who continue to hold Shares by increasing their equity interest in the Company when the repurchased Shares are cancelled.
Under the Company's current normal course issuer bid that commenced December 31, 2021 and terminates December 30, 2022, the Company was authorized to purchase up to 1,855,938 Shares. Under that bid, the Company has purchased 1,201,828 Shares through open market purchases at a volume weighted average price of $28.72 per Share during the period from December 31, 2021 to December 20, 2022.
In connection with the Bid, the Company will enter into an automatic share purchase plan ("ASPP") with a designated broker. The ASPP is intended to allow for the purchase of Shares under the Bid at times when the Company would ordinarily not be permitted to purchase Shares due to regulatory restrictions and customary self-imposed blackout periods. Pursuant to the ASPP, before entering into a blackout period, the Company may, but is not required to, instruct the designated broker to make purchases under the Bid in accordance with the terms of the ASPP. Such purchases will be determined by the designated broker at its sole discretion based on purchasing parameters set by the Company in accordance with the rules of the TSX and any applicable alternative Canadian trading system, applicable securities laws and the terms of the ASPP. The ASPP will be in effect for the term of the Bid.
About ADENTRA
ADENTRA is one of North America's largest distributors of architectural products to fabricators, home centers, and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The Company currently operates a network in North America of 86 facilities in the United States and Canada. ADENTRA's common shares are listed on the Toronto Stock Exchange under the symbol "ADEN".
Website: www.ADENTRAgroup.com
SOURCE ADENTRA Inc. Cision
View original content: http://www.newswire.ca/en/releases/archive/December2022/29/c4059.html
ADENTRA Announces Normal Course Issuer Bid
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...